Raymond James Upgrades WAVE Life Sciences to Strong Buy, Raises Price Target to $22

Benzinga · 10/16 17:28
Raymond James analyst Steven Seedhouse upgrades WAVE Life Sciences (NASDAQ:WVE) from Outperform to Strong Buy and raises the price target from $13 to $22.